Nihon Kohden Corporation (TYO:6849)
1,832.00
+15.50 (0.85%)
Jan 23, 2026, 3:30 PM JST
Nihon Kohden Revenue
Nihon Kohden had revenue of 58.10B JPY in the quarter ending September 30, 2025, with 2.73% growth. This brings the company's revenue in the last twelve months to 230.76B, up 4.31% year-over-year. In the fiscal year ending March 31, 2025, Nihon Kohden had annual revenue of 225.42B with 1.55% growth.
Revenue (ttm)
230.76B
Revenue Growth
+4.31%
P/S Ratio
1.29
Revenue / Employee
37.74M
Employees
6,114
Market Cap
297.50B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 225.42B | 3.44B | 1.55% |
| Mar 31, 2024 | 221.99B | 15.38B | 7.45% |
| Mar 31, 2023 | 206.60B | 1.47B | 0.72% |
| Mar 31, 2022 | 205.13B | 5.40B | 2.70% |
| Mar 31, 2021 | 199.73B | 14.72B | 7.96% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PHC Holdings | 361.11B |
| Fukuda Denshi | 139.50B |
| Japan Lifeline | 57.91B |
| Eiken Chemical | 41.24B |
| Seikagaku | 37.07B |
| Rion Co., Ltd. | 28.46B |
| Japan Medical Dynamic Marketing, INC. | 24.91B |
| Techno Medica | 9.89B |
Nihon Kohden News
- 7 weeks ago - Nihon Kohden Brings Advanced EEG Technology Built on 70 Years of Innovation to Booth #725 at the American Epilepsy Society 2025 Annual Meeting - Business Wire